SARS-CoV-2 Variant HV.1; Obsolete Boosters
No evidence that current boosters are "safe and effective" against dominant HV.1 variant
As previously covered (here), the currently available FDA emergency use authorized “booster vaccines” were designed based on recommendations developed at the FDA VRPBAC (vaccine and related products biological advisory committee), which predicted that the dominant SARS-CoV-2 variant this fall would be the “Kraken” (XBB.1.5) viral variant of Omicron.